BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
British Journal of Ophthalmology 2008;92:727-728; doi:10.1136/bjo.2007.133249
Copyright © 2008 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Singh, A. D
Right arrow Articles by Bena, J. F
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, A. D
Right arrow Articles by Bena, J. F
Topic Collections
Right arrowRelated Articles

EDITORIAL

Editorial

Primary transpupillary thermotherapy of "small" choroidal melanoma: is it safe?

Arun D Singh1, Tero Kivelä2, Stefan Seregard3, Dennis Robertson4, James F Bena5

1 Department of Ophthalmic Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA
2 Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
3 Department of Vitreoretinal Diseases, St Erik’s Eye Hospital, Stockholm, Sweden
4 Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA
5 Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA

Correspondence to:
Dr A D Singh, Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA; singha@ccf.org

Accepted 22 March 2008

The first 150 words of the full text of this article appear below.

Transpupillary thermotherapy (TTT) of choroidal melanoma, initially described to be used primarily in combination with plaque radiotherapy in 1995,1 2 has been subsequently used by several investigators, particularly in the United States as primary or sole therapy for "small" choroidal melanocytic lesions (melanomas or high-risk nevi with or without documented growth) (table 1). While the technique of TTT used by the investigators is similar (2–3 mm spot size, inclusion of 1 mm margin, overlapping spots, one to three applications 3–4 months apart), the inclusion criteria for selecting the patients to be treated with TTT has varied between series, although most investigators excluded tumours that were more than 4 mm in height.3 4


View this table:



  		Table 1 Primary transpupillary thermotherapy of "small" choroidal melanoma: summary of data

 
Following the initial encouraging results as primary therapy without brachytherapy,5 TTT rapidly increased in popularity because of its ease of use in the office setting and wide . . . [Full text of this article]


Related Articles

Primary transpupillary thermotherapy for small choroidal melanomas
Y Pan, K Diddie, and J I Lim
Br. J. Ophthalmol. 2008 92: 747-750. [Abstract] [Full Text] [PDF]

Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma
T M Aaberg, Jr, C S Bergstrom, Z J Hickner, and M J Lynn
Br. J. Ophthalmol. 2008 92: 741-746. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.